trendless on Nostr: https://www.sciencedaily.com/releases/2024/01/240112114749.htm > Researchers from the ...
https://www.sciencedaily.com/releases/2024/01/240112114749.htm
> Researchers from the Infection Biology Lab at the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University and the HIV Unit at Hospital del Mar Research Institute have shown that intradermal vaccination with the JYNNEOS vaccine against smallpox is the best option to protect people living with HIV from contracting the monkeypox virus. This route of vaccine administration requires less material to inject each patient, extending the available vaccine doses by a factor of five. The results of this observational study also indicate that individuals with a low level of CD4 T cells, a type of white blood cell essential to properly fight new infections, need a booster dose 28 days after the first dose to compensate for their immunosuppressed status.
🔗 Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination (December 2023) https://onlinelibrary.wiley.com/doi/10.1002/jmv.29317
> Researchers from the Infection Biology Lab at the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University and the HIV Unit at Hospital del Mar Research Institute have shown that intradermal vaccination with the JYNNEOS vaccine against smallpox is the best option to protect people living with HIV from contracting the monkeypox virus. This route of vaccine administration requires less material to inject each patient, extending the available vaccine doses by a factor of five. The results of this observational study also indicate that individuals with a low level of CD4 T cells, a type of white blood cell essential to properly fight new infections, need a booster dose 28 days after the first dose to compensate for their immunosuppressed status.
🔗 Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination (December 2023) https://onlinelibrary.wiley.com/doi/10.1002/jmv.29317